戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 complex formed between sulfonyl chloride and sodium iodide.
2 nistration of approximately 28 MBq of (124)I-sodium iodide.
3 tient administration of larger activities of sodium iodide 131I than previously permitted.
4 MYMD-1 (185 mg/l) or water supplemented with sodium iodide (500 mg/l) that contained (16 mice) or did
5 y coupling with AZT and O-demethylation with sodium iodide, afforded 3'-azido-3'-deoxy-5'-O-[[(1-octa
6                   By in situ 1) oxidation of sodium iodide and 2) sequestration of the transiently ge
7  characteristics, and only 2 (thallium-doped sodium iodide and bismuth germanate) have found widespre
8 ith increasing glycosaminoglycan content for sodium iodide and Gd-DTPA only, diffusivity significantl
9 h significant decreases in diffusivities for sodium iodide and Gd-DTPA, with similar (but not signifi
10 ted by the presence of 10 mg/L soap, 15 mg/L sodium iodide, and 6000 mg/L sodium thiosulfate.
11 substituted by silver acetate, sodium azide, sodium iodide, and silver nitrate.
12  the corresponding sugar aldehydes through a sodium iodide-catalyzed Henry reaction with bromonitrome
13 h sodium bromide or sodium chloride, but not sodium iodide, competitively oxidized some haloalcohols
14 ction of tertiary amides by a sodium hydride/sodium iodide composite, in situ treatment of the result
15 ion conducted a model-independent test using sodium iodide crystal detectors, the same target materia
16  The camera uses a 10 x 10 cm thallium-doped sodium iodide crystal, a 2 x 2 array of 53 x 53 mm photo
17 OET clearance was monitored for 1 hr using a sodium iodide detector in 22 isolated, buffer-perfused r
18       Mechanistic explanations for the large sodium iodide effect as well as possible mechanistic pat
19 generation of hydroiodic acid from catalytic sodium iodide, employing phosphorus acid as the stoichio
20 nerated from bis(trifluoromethyl)mercury and sodium iodide] gave fused-ring 2,2-difluorocyclopropane
21 nctional CCR6, as detected by the binding of sodium iodide I 125-labeled liver and activation-regulat
22        Exposure of the as-isolated AcN2OR to sodium iodide led to reduction of the electron-donating
23 S) analysis in positive detection mode using sodium iodide (NaI) as an additive.
24 during DNA isolation is eliminated using the sodium iodide (NaI) isolation method and that the level
25           By simple combination of water and sodium iodide (NaI) with chlorotrimethylsilane (TMSCl),
26 rcent of IFN-gamma(-/-) NOD.H-2h4 mice given sodium iodide (NaI)-supplemented water develop a slow on
27 iment, consisting of 106 kg of tallium-doped sodium iodide [NaI(Tl)] target material, is aimed to tes
28          Four hours after being given (123)I-sodium iodide orally, each patient received (99m)Tc-sest
29 um iodide SPECT/CT, (99m)Tc-sestamibi/(123)I-sodium iodide planar subtraction imaging, and (99m)Tc-se
30 ernal environment, as seen by an increase in sodium iodide quenching.
31 on, fluorescence-quenching experiments using sodium iodide revealed a small reduction in the extent o
32 ed diffusivities as the smallest one tested, sodium iodide, showed higher diffusivity than sodium dia
33 single-wavelength anomalous dispersion using sodium-iodide-soaked crystals and diffraction data colle
34 n diffusion of three common contrast agents: sodium iodide, sodium diatrizoate, and gadolinium diethy
35            Mixing copper(II) perchlorate and sodium iodide solutions results in copper(I) species and
36 aphy, consisting of (99m)Tc-sestamibi/(123)I-sodium iodide SPECT/CT, (99m)Tc-sestamibi/(123)I-sodium
37                    We incorporated the human sodium iodide symporter (hNIS) and the human somatostati
38 differentiation, including the loss of human sodium iodide symporter (hNIS) expression, radioactive i
39  carcinoembryonic antigen (CEA) or the human sodium iodide symporter (hNIS) for oncolytic potential i
40 ionuclide accumulation mediated by the human sodium iodide symporter (hNIS) gene in conjunction with
41 ntification of cardiac gene expression after sodium iodide symporter (hNIS) gene transfer in cardiac
42 ic vaccinia virus, GLV-1h153, carrying human sodium iodide symporter (hNIS), in combination with radi
43 virus (VSV)-murine interferon beta (IFNbeta)-sodium iodide symporter (NIS) (VSV-mIFNbeta-NIS) oncolyt
44 second strategy involves transduction of the sodium iodide symporter (NIS) and free radionuclide ther
45 cells with retroviral vectors containing the sodium iodide symporter (NIS) and thyroperoxidase (TPO)
46 aft breast cancer model expressing the human sodium iodide symporter (NIS) as a reporter.
47                           The application of sodium iodide symporter (NIS) as a theranostic gene allo
48            In the current study, we used the sodium iodide symporter (NIS) as a theranostic gene to i
49  cancer cells to express functionally active sodium iodide symporter (NIS) by targeted NIS gene trans
50 ast cancer cells stably expressing the human sodium iodide symporter (NIS) fused to a red fluorescent
51 n the matrix protein and expresses the human sodium iodide symporter (NIS) gene.
52                                          The sodium iodide symporter (NIS) is required for iodide upt
53                                          The sodium iodide symporter (NIS) is widely used as a report
54                                          The sodium iodide symporter (NIS) mediates iodide uptake int
55 its binding factor PBF repress expression of sodium iodide symporter (NIS) messenger RNA (mRNA), and
56                               In this study, sodium iodide symporter (NIS) transgene imaging was eval
57  cancer cells to express functionally active sodium iodide symporter (NIS) would enable those cells t
58 din-Darby canine kidney cells expressing the sodium iodide symporter (NIS), pendrin, or NIS and pendr
59 ne levels by up-regulating expression of the sodium iodide symporter (NIS), thyroid peroxidase (TPO),
60 T tracer with excellent properties for human sodium iodide symporter (NIS)-based imaging in patients
61  is one of the most promising candidates for sodium iodide symporter (NIS)-mediated gene therapy.
62 f therapeutic genes, such as the theranostic sodium iodide symporter (NIS).
63 receptor expressing cells also expressed the sodium iodide symporter and thyroglobulin genes.
64                                              Sodium iodide symporter expression in patient tumors aft
65                 MV engineered to express the sodium iodide symporter gene (MV-NIS) facilitates locali
66 profound inhibition of the expression of the sodium iodide symporter gene.
67 ted with a vaccinia virus carrying the human sodium iodide symporter GLV-1h153.
68 isease, based on decreased expression of the sodium iodide symporter SLC5A5 (NIS), diminished membran
69 A levels for thyroglobulin, thyroperoxidase, sodium iodide symporter, and deiodinase type 2, and deio
70 tinib, which modulates the expression of the sodium iodide symporter, and hence iodine uptake, in the
71 2, sodium hydrogen exchanger 3, aquaporin 7, sodium iodide symporter, and hydrogen potassium adenosin
72 Pax-8, thereby suppressing expression of the sodium iodide symporter, thyroid peroxidase, TG, and thy
73 thyroid-specific target genes thyroglobulin, sodium iodide symporter, thyroperoxidase, and thyroid-st
74                 Anion transport by the human sodium-iodide symporter (hNIS) is an established target
75 man norepinephrine transporter (hNET), human sodium-iodide symporter (hNIS), a human deoxycytidine ki
76  and polymerase chain reaction for gal-3 and sodium-iodide symporter (NIS) expression.
77                              We examined the sodium-iodide symporter (NIS), which promotes in vivo ce
78 h uptake into thyroid tissue mediated by the sodium-iodide symporter (NIS).
79 y antagonists increase the expression of the sodium-iodide symporter and uptake of iodine.
80 HR expression was required for expression of sodium-iodide symporter but was not required for thyrogl
81  this observation was the lack of detectable sodium-iodide symporter expression in TSHR-KO thyroid gl
82                                      BLI and sodium-iodide symporter imaging may be useful for in viv
83 nal obtained by firefly luciferase and human sodium-iodide symporter labeling of cardiosphere-derived
84 ansmembrane receptor Smoothened, and 13-pass Sodium-iodide symporter to extracellular vesicles (EVs)
85 9m)technetium pertechnetate (mediated by the sodium-iodide symporter), (99m)technetium sestamibi (car
86 as attributed to decreased expression of the sodium-iodide symporter.
87  virus type I thymidine kinase and the human sodium-iodide symporter.
88 yroid-stimulating hormone in stimulating the sodium-iodide symporter.
89  novel PET radioligand for imaging the human sodium/iodide symporter (hNIS).
90 t tissue and some breast cancers express the sodium/iodide symporter (NIS) and concentrate iodide.
91                                          The sodium/iodide symporter (NIS) concentrates iodide in the
92                                          The sodium/iodide symporter (NIS) has been identified as an
93    Perchlorate, thiocyanate, and nitrate are sodium/iodide symporter (NIS) inhibitors that block iodi
94                                          The sodium/iodide symporter (NIS) is the essential plasma me
95                                          The sodium/iodide symporter (NIS) is under investigation as
96                                          The sodium/iodide symporter (NIS) mediates active I(-) trans
97                                          The sodium/iodide symporter (NIS) mediates active iodide (I(
98 sitron emission tomography imaging using the sodium/iodide symporter (NIS) reporter gene revealed sta
99                                          The sodium/iodide symporter (NIS) stimulates iodide uptake i
100 ds to the 3'-untranslated region of PAX8 and sodium/iodide symporter (NIS), leading to impaired prote
101 wn that RET/PTC1 decreases expression of the sodium/iodide symporter (NIS), the molecule that mediate
102 se model of hypothyroidism: mice lacking the sodium/iodide symporter (NIS), the plasma membrane prote
103 in the thyroid and breast is mediated by the sodium/iodide symporter (NIS).
104  functional role in tumor progression of the sodium/iodide symporter (NIS; aka SLC5A5), which is upre
105                                      The rat sodium/iodide symporter gene (rNIS) was cloned into a re
106  Here we show that a specialized form of the sodium/iodide symporter in the mammary gland mediates ac
107 hese results indicate that the mammary gland sodium/iodide symporter may be an essential breast cance
108                                          The sodium/iodide symporter mediates active iodide transport
109 pression of TTF1 increased thyroglobulin and sodium/iodide symporter mRNA levels, cell migration, and
110 mputed tomography imaging of the hNIS (human sodium/iodide symporter) to noninvasively quantify adeno
111 sed expression of thyroglobulin (Tg) and the sodium/iodide symporter).
112 the hormonal regulation of the mammary gland sodium/iodide symporter, we demonstrate by scintigraphy
113 egulated expression of thyroglobulin and the sodium/iodide symporter.
114                              The addition of sodium iodide to catalysts 2a-4a (to form 2b-4b in situ)
115 /6 mice) of various ages were measured using sodium iodide to prevent oxidative damage to DNA during
116                       Addition of 1 equiv of sodium iodide to the reaction improved the chemoselectiv
117 ogenic anion that competitively inhibits the sodium iodide transporter and has been detected in forag
118 ng hormone receptor, thyroid peroxidase, and sodium iodide transporter.
119 luorine 18 fluorodeoxyglucose and iodine 131 sodium iodide were generated.
120 1 h plus an additional separation step using sodium iodide which can be used to reduce mineral residu
121 ormation of the CF2I group is based on using sodium iodide, with the sodium serving as a scavenger of
122  of one methyl group from the triesters with sodium iodide yielded monosodium salts, whereas treatmen

 
Page Top